Seeing Eye to Eye with ROI
By Sarah Medina Rodriguez, Clinical Research Operations Leader
As a Research Director, I’ve long known what my team needs before a new study even lands on our desk. It’s a gut feeling backed by years of operational insight when to scale, when to hire, and when to sound the alarm on burnout.
But no matter how accurate my instincts have been, walking into a C-suite meeting to justify a new full-time equivalent (FTE) has historically been an uphill battle. That changed when I found a way to translate that instinct into strategy.
This is my story. It’s one that many clinical trials site leaders will recognize—and, I hope, find useful.
The Disconnect: Knowing the Need, Explaining the Why
In the past, when I knew it was time to grow the team, I relied on my operational metrics, gut sense, and staff feedback. But in front of a finance committee or executive panel, that approach didn’t land.
Executives needed more than urgency. They needed evidence quantifiable ROI, financial forecasts, and justification tied to risk and reward.
I knew the team was maxed out. They were staying late, chasing timelines, and shouldering backlogs. But how do you convert that into a business case?
The workload imbalance was visible to us on the ground but not easily understood by leadership. We had to work within a 40-hour week, even when our protocols demanded 60. We were burning out our talented staff, and it was only a matter of time before quality would be affected.
TRIALNAV: A Partner, Not Just a Platform
I first came across TRIALNAV by accident. But the timing could not have been more perfect.
As I began planning for a strategic staffing expansion, I knew I would need more than intuition. I worked with my Chief Operating Officer and HR to outline the types of roles we needed to meet future trial demands.
That is when I engaged with the TRIALNAV team. I brought them raw data—trial volume projections, salary benchmarks, current workloads and they brought me clarity. Together, we created an ROI-backed staffing model grounded in data my leadership could understand.
TRIALNAV didn’t just show me the numbers—they helped me build a story leadership could trust.
The Process: Making the Case with Confidence
TRIALNAV gave me a framework to move from anecdotal justification to strategic planning. We looked at:
· Study budgets vs. personnel costs.
· Participant enrollment forecasts
· Protocol complexity indexes.
· Time-to-revenue models for each role
· Historical delays tied to understaffing.
This allowed me to present staffing not as a request—but as a return on investment. Every role was tied to study performance, financial recovery, and patient safety.
When I walked into the FTE Justification Committee, I was no longer advocating based on operational urgency, I was presenting a business plan.
The Results: Building a Team for Growth
Thanks to this strategic approach, I secured approval for six key positions:
· Research Pharmacist
· Research Pharmacy Technician
· Research Nurse
· Research Financial Analyst
· Research Medicare Coverage Analyst
· Research Administrative Systems Analyst
Each of these roles addressed a critical operational gap. Together, they formed a cohesive unit positioned not just to survive, but to thrive. More importantly, they allowed us to say “yes” to more complex trials without compromising our team or timelines.
We stopped asking for help and started showing the value of investment.
Lessons Learned: What I would Tell Other Site Leaders
1. Don’t lead with emotion, lead with evidence. Your team’s pain is real, but numbers move decision-makers.
2. Find your internal allies. Partner with HR, finance, and operations early in the process.
3. Use tools built for sites. TRIALNAV understands how we work—and more importantly, how to communicate that work to the C-suite.
4. Growth is not a luxury; it is a necessity. If you want to run more studies and deliver quality care, you need the infrastructure to support it.
Conclusion: A Seat at the Table
For too long, site operations have struggled to translate their value. With platforms like TRIALNAV, we are finally getting the tools to advocate for ourselves with confidence and credibility.
I did not just grow a team. I helped leadership see the research enterprise as an engine worth investing in.
And I am not alone. If you are a site leader trying to justify your next FTE, you don’t have to do it alone, either.
About the Author
Sarah Medina Rodriguez is a seasoned clinical trial operations leader with deep expertise in site strategy, staff development, and protocol implementation. She is passionate about empowering research teams with the tools and insights they need to grow, perform, and thrive in an increasingly complex clinical landscape.
About TRIALNAV
TRIALNAV OASIS is a research operations and staffing acuity platform designed specifically for clinical trial sites. It transforms operational complexity into clear, ROI-driven decisions that empower sites to grow with data, not guesswork.
Learn more at www.trialnav.com Reach out: [email protected]
